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INTRODUCTION
Among the critically ill patients with sepsis, multiple organ
failure and high mortality occurs in a significant proportion.
The development of sepsis occurs as a result of systemic in-
flammatory response syndrome to infection (Nystrom,
1998). However, the outcome of sepsis is not determined by
the infection itself, but mostly by the response of the host
(Cohen, 2002). A central part of host response is endothelial
cell dysfunction, which leads to vascular dysfunction and/or
injury. Sepsis induces a cascade of inflammatory cytokines
and mediators with vasoactive properties, such as nitric
oxyde (NO). Inducible nitric oxide appears to play a central
role in septic vascular dysfunction (Bone, 1991). Large ar-
teries can be affected as part of vascular dysfunction. Data
obtained in experimental studies show that acute systemic
inflammation leads to a temporary increase of large artery
stiffness (Vlachopoulos et al., 2005) but effect of massive
inflammatory response in early sepsis on large artery stiff-
ness has not been previously investigated.
Systemic arteries can be subdivided into two types — mus-
cular and elastic. Aorta is the largest elastic artery in the hu-
man body. The measurement of carotid to femoral pulse
wave velocity (PWV) is a recognised index of aortic disten-
sibility and stiffness, it can be measured noninvasively and
has been shown to be an important predictor of mortality in
various chronic diseases (Blacher et al., 1999, Blacher et
al., 1999, Stefanadis et al., 2000). The brachial artery is an
easily accessible muscular artery. Carotid to radial PWV,
which represents mainly brachial artery stiffness, is more
likely to be influenced by endothelial nitric oxide (eNO)
production than carotid to femoral PWV. Also, as vascular
dysfunction in sepsis is functionally linked with basal eNO
production, it is likely to be more influenced by sepsis. The
objective of the study was to assess aortic and brachial stiff-
ness in patients with early severe sepsis and septic shock.
We investigated carotid to femoral and carotid to radial
PWV as an index of sepsis-induced changes in elastic and
muscular arteries, and the clinical, inflammatory, and
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Sepsis is characterised by massive inflammatory response, which can affect vascular function.
This study was designed to assess the impact of early severe sepsis and septic shock on arterial
stiffness and the relationship of this impact to outcome. Twelve patients with severe sepsis and
22 with septic shock were included in the study. We measured carotid to femoral and carotid to
radial pulse wave velocity (PWV), an index of aortic and brachial arterial stiffness, in patients with
early severe sepsis and septic shock within 24 hours of admission to intensive care unit and re-
peatedly after 48 hours. No difference was observed between patients with severe sepsis and
septic shock regarding carotid to femoral PWV (11.7 ± 2.2 vs. 11.3 ± 3.6 m/s) and carotid to ra-
dial PWV (12.0 ± 3.8 vs. 9.5 ± 2.2 m/s). On 48 hour follow-up, PWV did not significantly differ be-
tween survivors and non-survivors. A positive, similar correlation occurred between PWV and
pulse pressure in all patients (r = 0.35, p = 0.05), and there was a negative correlation between
PWV and C-reactive protein levels (r = -0.43, p = 0.04). In conclusion, PWV is not affected by dis-
ease severity or prognosis.
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haemodynamic parameters correlated with PWV in such pa-
tients and their relationship to outcome.
MATERIALS AND METHODS
The investigation was conducted according to the principles
outlined in the Declaration of Helsinki. The study protocol
was approved by Rîga Stradiòð University Ethics Commit-
tee and informed consent was given by each patient or their
next of kin.
Study population. Consecutive patients hospitalised to the
12-bed Toxicology and Sepsis Clinic of Rîga East Clinical
University Hospital “Gaiïezers” with a diagnosis of severe
sepsis or septic shock were enrolled (Levy et al., 2003). Pa-
tients were excluded if they were pregnant, aged <18 years,
were requiring nitroglycerin or had aortic surgery. Septic
shock was defined as severe sepsis with sepsis-induced hy-
potension persisting despite adequate fluid resuscitation,
and requiring the administration of vasopressor agents. The
clinical management of each patient was determined by
clinical staff in accordance with local guidelines.
Pulse wave velocity measurement. Pulse wave velocity
(PWV) was measured using an originally designed two-
channel photoplethysmograph (PPG) (LU ASI, Latvia) with
the patient in supine decubitus position. Two reflecting sen-
sor probes were used to measure the arterial waveforms,
first at carotid and femoral arteries, then at carotid and ra-
dial arteries. The analogue signals from PPG contact probes
were digitised by an analogue-to-digital converter (16-bit
accuracy, sampling rate 300 Hz) and transferred to the com-
puter (Erts, 2005). The time delay between upstrokes of the
two simultaneous arterial waveforms was measured using
the ‘foot-to-foot’ method to obtain transit time of the arte-
rial pulse wave along the artery, T. The measured surface
body distance in metres (m) between both measurement
points (carotid and femoral arteries, and carotid and radial,
respectively), L, was multiplied by 0.8, as this yields the
best agreement with the reference aortic path length
(Huybrechts et al., 2011). PWV in m/s was calculated using
the equation: PWV = L*0.8/T.
Study protocol. Patients were enrolled within 24 h after ad-
mission to the Intensive Care Unit. Information collected at
enrolment included demographic characteristics on age, sex,
weight, and height (to calculate body mass index, BMI);
Acute Physiology and Chronic Health Evaluation
(APACHE) II score (Knaus 1985); Sequential Organ Fail-
ure Assessment (SOFA) score (Vincent et al., 1996); and
primary site and type of infection.
When the patient was haemodynamically stable (mean arte-
rial pressure (MAP) > 65 mmHg and no change in vaso-
pressor infusion rate for 1 h), the PPG probes were placed
on the skin over maximal pulsation of carotid artery on the
neck and femoral artery in the groin for recording of carotid
to femoral pulse wave delay, and on the skin over maximal
pulsation of carotid artery on the neck and radial artery on
the wrist for recording of carotid to radial pulse wave time
delay. The PPG signal was recorded for 3 minutes on both
sites. This process was repeated in 48 hours.
The following measurements were also obtained: arterial
pressure; doses of vasopressor agents.
Statistical analysis. Discrete variables are expressed as
counts (percentage) and continuous variables as mean ± SD
or median (25th–75th percentiles). For demographic and
clinical characteristics, differences between groups were as-
sessed using a chi-square, Fisher’s exact test, Student’s t-
test, or Mann–Whitney U-test. For the PWV variables in the
different study groups, analysis of variance followed by a
Tukey (HSD) test with adjustment for multiple comparisons
or a Kruskal–Wallis test were used. Linear regression analy-
sis (Pearson’s analysis) was used to assess correlations of
continuous variables. We considered p < 0.05 to be signifi-
cant.
RESULTS
We studied 34 patients with severe sepsis (median age 62
years, interquartile range 50–76), including 12 patients
without and 22 patients with septic shock (Table 1). Char-
acteristics of the study groups are shown in Table 2.
Pulse wave velocity. Carotid to femoral pulse wave veloc-
ity was not recordable in one male patient from the septic
shock group due to bilateral above knee amputation secon-
dary to peripheral vascular disease. Carotid to femoral and
carotid to radial PWV values for patient groups with severe
sepsis and septic shock are shown in Figure 1. No differ-
ence was observed between the groups (p = 0.88). Median
values for carotid to femoral PWV were 11.7 ± 2.2 m/s in
the severe sepsis group (range 8.4 to 16.6), 11.3 ± 3.6 m/s
in the septic shock group (range 7.1 to 18.0), median values
for carotid to radial PWV were 12.0 ± 3.8 m/s in the severe
T a b l e 1
CLINICAL DATA OF PATIENTS (n = 34)
Primary site of infection (n, %)
Respiratory tract 11 (32)
Abdomen 10 (29)
Urinary tract 3 (9)
Skin/soft tissue 6 (18)
Other 2 (6)
Unknown 2 (6)
Type of organism (n,%)
Gram positive 15 (44)
Gram negative 3 (9)
Mixed 5 (15)
Unknown 10 (29)
Vasoactive agents (n; dose in mcg/kg·min-1)
Noradrenaline 19; 0.09 (0.06–0.12)
Non-survivors (n, %) 9 (26)
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sepsis group (range 7.6 to 24.9), 9.5 ± 2.2 m/s in the septic
shock group (range 6.0 to 14.9).
Determinants of PWV in septic patients. We observed a
significant correlation between carotid to femoral PWV and
pulse pressure (r2 = 0.35, p = 0.05) (Fig. 2). Carotid to
femoral pulse wave velocity negatively correlated with C-
reactive protein levels (r2 = –0.43, p = 0.04) (Fig. 3). There
was no correlation between carotid to femoral PWV and age
(r2 = 0.02).
No correlation between carotid to radial PWV and pulse
pressure (r2 = 0.05), C-reactive protein concentration (r2 =
0.07) or noradrenaline dose (r2 = 0.02) was found.
Follow-up. The 28-day mortality in the 34 septic patients
was 26%. Two patients from the septic shock group died
within 48 hours of admission, so no follow-up recording
was possible. Median change in carotid-femoral PWV was
–2.9 ± 4.6 m/s in survivors and 4.3 ± 7.3 m/s in non-
survivors, and median change in carotid-radial PWV was
–1.8 ± 1.4 m/s in survivors and 2.4 ± 4.3 in non-survivors.
The change in carotid to femoral and carotid to radial PWV
did not significantly different between survivor and non-
survivor groups (p = 0.6) (Fig. 4).
DISCUSSION
This prospective, observational study characterises and
quantifies sepsis-induced alterations in arterial stiffness in
T a b l e 2








Age (years) 62 (50.25–75.75) 60 (44.5–72.5) 76 (57–81)
Male (n, %) 19 (56) 16 (64) 3 (33)
BMI 26.25 (24.5–28.2) 25.7 (24.5–27.8) 25.7 (24.4–27)
MAP (mm Hg) 75 (70–81) 78.5 (70–85.5) 74 (69.5–77)
APACHE II 18.5 (14–24) 15.5 (13.5–20.25)* 27 (24–30)*
Initial SOFA 6.5 (4–9) 5 (4–7.5)* 11(9–12)*
Delta SOFA 3 (1–4.25) 3 (2–4) –1(–1–5)
BMI, body mass index; MAP, mean arterial pressure.
*Significant difference at p = 5%
Fig. 1. Carotid-femoral and carotid-radial pulse wave velocity values for
patients with severe sepsis and septic shock (p = 0.88).
Fig. 2. Relationship between carotid to femoral pulse wave velocity and
pulse pressure in patients with early sepsis (r = 0.35, p = 0.05).
Fig. 3. Relationship between carotid to femoral pulse wave velocity and
C-reactive protein concentration in patients with early sepsis (r = –0.43,
p = 0.04).
Fig. 4. Time course of carotid to femoral PWV (median ± SE) in survivors
(n = 25; circles) and non-survivors (n = 9; triangles) at baseline (24 h), and
after 48 h in 34 septic patients.
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elastic and muscular arteries. We demonstrated that PWV, a
recognised index of arterial stiffness, is not modified in pa-
tients with severe sepsis compared with patients with septic
shock. Likewise, PWV and its change over 48 hours of
early sepsis was not related to patient outcome. Carotid to
femoral and carotid to radial PWV was correlated with
pulse pressure, and carotid to femoral PWV was negatively
correlated with inflammatory status.
Although PWV is not a direct measure of arterial distensi-
bility, several reports have considered it an important index
of arterial stiffness and consequently, arterial distensibility.
There are some cardiovascular risk factors that can modify
arterial distensibility and PWV measurement differently.
However, important factors like age and blood pressure in-
terfere similarly with both arterial distensibility and PWV
measurement.
In our cohort of patients with severe sepsis and septic
shock, median carotid-to-femoral PWV was 11.2 m/s at
baseline and 9.3 m/s at follow up (after 48 hours). The val-
ues are very similar to results of a large recent study estab-
lishing normal and reference values for carotid to femoral
PWV based on a data set obtained from 13 centres distrib-
uted across Europe (Anonymous, 2010). No large popula-
tion studies have been done examining reference values for
carotid to radial PWV. However, as the carotid to radial
PWV values do not significantly differ from carotid to
femoral PWV values in this study, it can be assumed they
are in the normal range for the general population. A sub-
group of patients in this study had lower than normal blood
pressure, and it is difficult to interpret PWV as no reference
values currently exist.
Numerous publications and several reviews (Oliver and
Webb, 2003; Zieman et al., 2005) reported various patho-
physiological conditions associated with changed, mainly
increased, arterial stiffness associated with structural artery
wall changes. Most of them describe the effect of aging, but
also (Boutouyrie and Vermeersch, 2010) include the follow-
ing: physiological conditions, such as menopausal status
(Tanaka et al., 1998), genetic background, such as family
history of myocardial infarction (Riley et al.,1986) and ge-
netic polymorphisms (Benetos et al., 1995); cardiovascular
risk factors, such as smoking (Kool et al., 1993) and/or high
C- reactive protein (CRP) level (Yasmin et al., 2004); and
cardiovascular diseases, for example, coronary heart disease
(Boutouyrie et al., 2002). Acute systemic inflammation,
which characterises severe sepsis and septic shock, is un-
likely to induce structural artery wall changes because of
the short timeframe.
Another group of primarily non-cardiovascular diseases,
such as rheumatoid arthritis (Klocke et al., 2003, Turesson
et al., 2005), systemic vasculitides (Booth et al., 2004) and
systemic lupus erythematosus (Selzer et al., 2001), have
been described in studies as associated with changes in aor-
tic rigidity, showing the role of inflammation in the stiffen-
ing of large arteries. The inflammation process, either acute
during Salmonella typhi vaccination (Vlachopoulos et al.,
2005) or chronic during rheumatoid arthritis or systemic
lupus erythematosus, can cause stiffening through various
mechanisms, including endothelial dysfunction, cell release
of any number of inducible matrix metalloproteinases (in-
cluding MMP-9), medial calcifications, modified proteo-
glycan composition and hydration state, and/or cell infiltra-
tion around the vasa vasorum leading to vessel ischemia
(Roman et al., 2005, Maki-Petaja et al., 2006). The primary
proinflammatory cytokines, TNFa, and interleukin-6, are
the main inducers of hepatic CRP synthesis. In untreated
patients with essential hypertension, aortic stiffness, as-
sessed with carotid-to-femoral PWV, was significantly as-
sociated with CRP and interleukin-6 (Mahmud and Feely,
2005). In contrast to the previously published data, in this
study high CRP concentrations were associated with lower
carotid-to-femoral PWV. The studies describing association
of CRP and PWV have enrolled patients with low grade in-
flammation, and in cases of a massive inflammatory re-
sponse, the impact of CRP concentration on PWV could be
different.
Because sepsis is a dynamic state and haemodynamic pa-
rameters can change quickly, functional determinants of
PWV may play a significant role. Functional factors that
can cause alterations in arterial distensibility include mean
and pulse arterial pressure values and smooth muscle cell
tone of the arterial wall, in relation to adrenergic activity. In
our study, the correlation of PWV and pulse pressure was
statistically significant in all sepsis patients, supporting the
data indicating that the influence of blood pressure on vas-
cular properties is not modified in septic patients. There was
no clear effect of added adrenergic activity on PWV mea-
surement of patients requiring vasopressors and those with-
out vasopressor support.
This study was the first to assess longitudinal changes in ar-
terial stiffness in a cohort of patients with severe sepsis and
septic shock and examine the influence of haemodynamic
parameters and inflammation on arterial stiffness. However,
it has some limitations. The patient population was hetero-
geneous concerning disease severity and treatment and the
sample size was relatively small. There are no reliable refer-
ence values for PWV when measured at lower than normal
blood pressures. Functional factors have marked influence
on PWV, which could make the reproducibility of isolated
measurements questionable, raising the importance of lon-
gitudinal assessment. Possible confounders that were not
measured include different levels of cardiovascular risk fac-
tors. The measurement of endothelial function could have
helped to explain changes in arterial stiffness in relation to
C-reactive protein concentration.
This study does not support the role of arterial stiffness in
early sepsis as a potential prognostic factor. The new find-
ing, which has not been described in previous literature, was
the negative correlation between PWV and C-reactive pro-
tein concentration under conditions of massive inflamma-
tory response.
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ARTÇRIJU CIETÎBA UN PULSA VIÏÒA IZPLATÎÐANÂS ÂTRUMS PACIENTIEM AR AGRÎNU SEPSI
Sepse izraisa masîvu iekaisuma reakciju, kas var ietekmçt asinsvadu funkciju. Ðî pçtîjuma mçríis ir noteikt pulsa viïòa izplatîðanâs âtrumu
(PVIÂ), artçriju cietîbas objektîvu râdîtâju, un tâ dinamiku pacientiem ar agrînu smagu sepsi un septisku ðoku un salîdzinât artçriju elastîgâs
îpaðîbas ar sepses iznâkumu. Pçtîjumâ tika iekïauti 12 pacienti ar smagu sepsi un 22 pacienti ar septisku ðoku. PVIÂ tika noteikts miega
artçrijas-femorâlajâ un miega artçrijas-brahiâlajâ baseinâ pirmajâs 24 stundâs pçc stacionçðanas intensîvâs terapijas nodaïâ un atkârtoti pçc
48 stundâm. PVIÂ pacientiem ar smagu sepsi un septisku ðoku neatðíîrâs ne miega artçrijas-femorâlajâ (11.7 ± 2.2 vs. 11.3 ± 3.6 m/s), ne
miega artçrijas-brahiâlajâ baseinâ (12.0 ± 3.8 vs. 9.5 ± 2.2 m/s ). Atkârtotâ mçrîjumâ pçc 48 stundâm PVIÂ bija lîdzîgs 25 izdzîvojuðo un 9
neizdzîvojuðo pacientu grupâs. Pozitîvu korelâciju novçroja starp PVIÂ un pulsa spiedienu visâs pacientu grupâs (r = 0.35, p = 0.05 ).
Zemâks PVIÂ korelçja ar augstâku C reaktîvâ proteîna koncentrâciju (r = -0.43, p = 0.04). Pacientiem ar agrînu sepsi PVIÂ ietekmç
hemodinamiskie (pulsa spiediens) un iekaisuma (C reaktîvais olbaltums) faktori, bet ne slimîbas smagums vai prognoze.
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